Viking Therapeutics ( VKTX 1.92%) stock is soaring. Two years ago, the share price hovered just above $2. Today, shares trade ...

The big question surrounding Viking Therapeutics today centers around its promising glucagon-like peptide 1 (GLP-1) drug, ...

In conclusion, no, it is not too late to buy Viking Therapeutics stock. Just be aware that the road to commercializing its ...

Wells Fargo has released its annual biopharma M&A screen, identifying 31 potential acquisition targets in the ...

Viking Therapeutics (NASDAQ: VKTX), a clinical-stage company focused on developing novel therapeutics for metabolic and ...

Breaking this down further, VK2735 might be a $30 billion-a-year drug in the making, depending on how the competitive ...

Raymond James raised the price target for the Viking Therapeutics Inc (NASDAQ:VKTX) stock from “an Outperform” to “a Strong buy”. The rating was released on May 16, 2024, according to finviz. We ...

Viking Therapeutics (VKTX) stock falls after Roche (RHHBY) posted promising Phase 1 results for its experimental obesity ...

Viking Therapeutics's VKTX short percent of float has risen 17.0% since its last report. The company recently reported that ...

Raymond James raised the price target for the Viking Therapeutics Inc (NASDAQ:VKTX) stock from “an Outperform” to “a Strong buy”. The rating was released on May 16, 2024, according to finviz. We ...